Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)
Launched by MARCO ANTONIO MORALES OSORIO · Oct 31, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called FIBROIA, is studying a new online rehabilitation program designed for people with fibromyalgia, a condition that causes widespread pain and fatigue. The program combines personalized exercises guided by artificial intelligence (AI) and education about how pain works in the body. The goal is to see if this approach can help reduce pain and improve physical function over 12 weeks. Participants will be divided into two groups: one will use the AI-guided program, while the other will receive standard care. The study will measure changes in pain levels and physical abilities, as well as overall quality of life.
To participate, individuals must be between 18 and 65 years old and have a confirmed diagnosis of fibromyalgia. They will also need access to a smartphone or computer and be able to follow the online program. The study is not open for recruitment yet, but it aims to reach a wide range of patients, especially those who may not have easy access to traditional in-person treatments. This research could lead to better and more accessible treatments for fibromyalgia in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of fibromyalgia according to the American College of Rheumatology criteria.
- • Age between 18 and 65 years.
- • Access to an internet-connected device (smartphone or computer).
- • Ability to participate in a tele-rehabilitation program.
- Exclusion Criteria:
- • Participation in another clinical trial in the last 3 months.
- • Pregnancy or breastfeeding.
- • Uncontrolled severe medical conditions that could interfere with the intervention (e.g., cardiac or pulmonary diseases).
- • Physical or cognitive impairments that prevent following the exercise program.
About Marco Antonio Morales Osorio
Marco Antonio Morales Osorio is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With extensive experience in the design, implementation, and management of clinical studies, he focuses on innovative therapeutic areas that address unmet medical needs. His leadership emphasizes rigorous adherence to regulatory standards and ethical practices, ensuring the integrity of data and the safety of participants. Through collaboration with healthcare professionals and research institutions, Morales Osorio aims to facilitate the development of groundbreaking treatments that enhance patient care and contribute to the scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Concepción, Biobio, Chile
Concepción, Región Del Biobio, Chile
Concepción, Biobio, Chile
Patients applied
Trial Officials
Marco Morales-Osorio, PhD
Principal Investigator
Universidad San Sebastian
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported